BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12221289)

  • 1. Ubiquitination of inducible nitric oxide synthase is required for its degradation.
    Kolodziejski PJ; Musial A; Koo JS; Eissa NT
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12315-20. PubMed ID: 12221289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation.
    Chen L; Kong X; Fu J; Xu Y; Fang S; Hua P; Luo L; Yin Z
    Cell Immunol; 2009; 258(1):38-43. PubMed ID: 19362296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway.
    Musial A; Eissa NT
    J Biol Chem; 2001 Jun; 276(26):24268-73. PubMed ID: 11312270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular formation of "undisruptable" dimers of inducible nitric oxide synthase.
    Kolodziejski PJ; Rashid MB; Eissa NT
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14263-8. PubMed ID: 14614131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitination and degradation of neuronal nitric-oxide synthase in vitro: dimer stabilization protects the enzyme from proteolysis.
    Dunbar AY; Kamada Y; Jenkins GJ; Lowe ER; Billecke SS; Osawa Y
    Mol Pharmacol; 2004 Oct; 66(4):964-9. PubMed ID: 15235101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination.
    Chow JM; Lin HY; Shen SC; Wu MS; Lin CW; Chiu WT; Lin CH; Chen YC
    Toxicol Appl Pharmacol; 2009 Jun; 237(3):357-65. PubMed ID: 19376148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 May; 271(2):353-7. PubMed ID: 10799301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide prevents cytokine-induced cytotoxicity via inhibition of inducible nitric oxide synthase expression in beta TC cells.
    Sekiya K; Nagasaki H; Ozaki N; Suzuki A; Miura Y; Oiso Y
    Biochem Biophys Res Commun; 2000 Nov; 278(1):211-6. PubMed ID: 11071874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
    Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
    Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide from the inducible nitric oxide synthase (iNOS) increases the expression of cytochrome P450 2E1 in iNOS-null hepatocytes in the absence of inflammatory stimuli.
    Zamora R; Vodovotz Y; Alarcon L; Betten B; Loughran PA; Aulak KS; Stuehr DJ; Gibson KF; Billiar TR
    Arch Biochem Biophys; 2001 Jun; 390(2):287-94. PubMed ID: 11396931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the iNOS pathway in inflammatory macrophages by low-dose X-irradiation in vitro. Is there a time dependence?
    Hildebrandt G; Loppnow G; Jahns J; Hindemith M; Anderegg U; Saalbach A; Kamprad F
    Strahlenther Onkol; 2003 Mar; 179(3):158-66. PubMed ID: 12627258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells.
    Donnelly LE; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 Jan; 26(1):144-51. PubMed ID: 11751214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant.
    Punjabi CJ; Laskin JD; Pendino KJ; Goller NL; Durham SK; Laskin DL
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):165-72. PubMed ID: 7519435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells.
    Kim YM; Paik SG
    Biochem Biophys Res Commun; 2005 Jan; 326(2):410-6. PubMed ID: 15582593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA; Owens MW; Grisham MB
    Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells.
    Felley-Bosco E; Bender FC; Courjault-Gautier F; Bron C; Quest AF
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14334-9. PubMed ID: 11114180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Nitrosation and regulation of inducible nitric oxide synthase.
    Mitchell DA; Erwin PA; Michel T; Marletta MA
    Biochemistry; 2005 Mar; 44(12):4636-47. PubMed ID: 15779890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A.
    Lin WC; Tsai PS; Huang CJ
    Anesth Analg; 2005 Jul; 101(1):226-32, table of contents. PubMed ID: 15976236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors.
    Kolodziejski PJ; Koo JS; Eissa NT
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18141-6. PubMed ID: 15601772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.